Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Benign Prostatic Hyperplasia Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4477882
  • 120 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Benign Prostatic Hyperplasia in recent years and the growth of consumers' demand is expected to drive the global Benign Prostatic Hyperplasia market.

Geographically, the global Benign Prostatic Hyperplasia market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Benign Prostatic Hyperplasia market in North America.

Significant participants active in the global Benign Prostatic Hyperplasia market include: Boehringer Ingelheim, Nymox Pharmaceutical Corporation, Allergan PLC, Sanofi, Teva Pharmaceutical Industries Limited, Pfizer Inc., Eli Lilly and Company, Astellas Pharma Inc., GlaxoSmithKline PLC, Sophiris Bio Corp....

Global Benign Prostatic Hyperplasia Market Segmentation:

Benign Prostatic Hyperplasia market, by Benign Prostatic Hyperplasia type:

Alpha-Blockers

5- Alpha-Reductase Inhibitors (5-Aris)

Alpha-Adrenergic Blockers

Phosphodiesterase-5 Enzyme Inhibitors

Other

…

Benign Prostatic Hyperplasia market, by Application:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

…

Benign Prostatic Hyperplasia Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Benign Prostatic Hyperplasia by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Benign Prostatic Hyperplasia Market-Segmentation

4.1 By Type

4.1.1 Alpha-Blockers

4.1.2 5- Alpha-Reductase Inhibitors (5-Aris)

4.1.3 Alpha-Adrenergic Blockers

4.1.4 Phosphodiesterase-5 Enzyme Inhibitors

4.1.5 Other

4.2 By End-User/Application Industry

4.2.1 Hospital Pharmacies

4.2.2 Retail Pharmacies

4.2.3 Online Pharmacies

4.3 By Geography

4.3.1 North America Benign Prostatic Hyperplasia Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Benign Prostatic Hyperplasia Production from 2014-2020

4.3.1.2 North America Benign Prostatic Hyperplasia Consumption from 2014-2020

4.3.1.3 North America Benign Prostatic Hyperplasia Import and Export from 2014-2020

4.3.1.4 North America Benign Prostatic Hyperplasia Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Benign Prostatic Hyperplasia Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Benign Prostatic Hyperplasia Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Benign Prostatic Hyperplasia Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Benign Prostatic Hyperplasia Production from 2014-2020

4.3.2.2 Europe Benign Prostatic Hyperplasia Consumption from 2014-2020

4.3.2.3 Europe Benign Prostatic Hyperplasia Import and Export from 2014-2020

4.3.2.4 Europe Benign Prostatic Hyperplasia Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Benign Prostatic Hyperplasia Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Benign Prostatic Hyperplasia Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Benign Prostatic Hyperplasia Production from 2014-2020

4.3.3.2 Asia-Pacific Benign Prostatic Hyperplasia Consumption from 2014-2020

4.3.3.3 Asia-Pacific Benign Prostatic Hyperplasia Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Benign Prostatic Hyperplasia Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Benign Prostatic Hyperplasia Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Benign Prostatic Hyperplasia Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Benign Prostatic Hyperplasia Production from 2014-2020

4.3.4.2 Latin America Benign Prostatic Hyperplasia Consumption from 2014-2020

4.3.4.3 Latin America Benign Prostatic Hyperplasia Import and Export from 2014-2020

4.3.4.4 Latin America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Benign Prostatic Hyperplasia Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Benign Prostatic Hyperplasia Production from 2014-2020

4.3.5.2 Middle East & Africa Benign Prostatic Hyperplasia Consumption from 2014-2020

4.3.5.3 Middle East & Africa Benign Prostatic Hyperplasia Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Benign Prostatic Hyperplasia Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Benign Prostatic Hyperplasia Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Boehringer Ingelheim

5.1.1 Boehringer Ingelheim Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Nymox Pharmaceutical Corporation

5.2.1 Nymox Pharmaceutical Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Nymox Pharmaceutical Corporation Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Allergan PLC

5.3.1 Allergan PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Allergan PLC Sales, Growth Rate and Global Market Share from 2014-2020

5.4 Sanofi

5.4.1 Sanofi Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 Sanofi Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Teva Pharmaceutical Industries Limited

5.5.1 Teva Pharmaceutical Industries Limited Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Teva Pharmaceutical Industries Limited Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Pfizer Inc.

5.6.1 Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Eli Lilly and Company

5.7.1 Eli Lilly and Company Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Eli Lilly and Company Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Astellas Pharma Inc.

5.8.1 Astellas Pharma Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Astellas Pharma Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.9 GlaxoSmithKline PLC

5.9.1 GlaxoSmithKline PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 GlaxoSmithKline PLC Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Sophiris Bio Corp.

5.10.1 Sophiris Bio Corp. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Sophiris Bio Corp. Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Benign Prostatic Hyperplasia Market from 2021-2026

7.1 Future Forecast of Global Benign Prostatic Hyperplasia Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Benign Prostatic Hyperplasia Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Benign Prostatic Hyperplasia Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Benign Prostatic Hyperplasia Market Value ($) and Growth Rate of Benign Prostatic Hyperplasia from 2014-2026

Global Benign Prostatic Hyperplasia Production and Growth Rate Segment by Product Types from 2014-2026F

Global Benign Prostatic Hyperplasia Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Benign Prostatic Hyperplasia Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Benign Prostatic Hyperplasia Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Alpha-Blockers of Benign Prostatic Hyperplasia

Figure 5- Alpha-Reductase Inhibitors (5-Aris) of Benign Prostatic Hyperplasia

Figure Alpha-Adrenergic Blockers of Benign Prostatic Hyperplasia

Figure Phosphodiesterase-5 Enzyme Inhibitors of Benign Prostatic Hyperplasia

Figure Other of Benign Prostatic Hyperplasia

Table Global Benign Prostatic Hyperplasia Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Benign Prostatic Hyperplasia Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Hospital Pharmacies of Benign Prostatic Hyperplasia

Figure Retail Pharmacies of Benign Prostatic Hyperplasia

Figure Online Pharmacies of Benign Prostatic Hyperplasia

Table Global Benign Prostatic Hyperplasia Production Value ($) by Regions

Table Global Benign Prostatic Hyperplasia Production Value Share by Regions

Table Global Benign Prostatic Hyperplasia Production by Regions

Table Global Benign Prostatic Hyperplasia Production Share by Regions

Table Global Benign Prostatic Hyperplasia Consumption by Regions

Table Global Benign Prostatic Hyperplasia Consumption Share by Regions

Figure North America Benign Prostatic Hyperplasia Production and Growth Rate from 2014-2020

Figure North America Benign Prostatic Hyperplasia Consumption and Growth Rate from 2014-2020

Table North America Benign Prostatic Hyperplasia Import and Export from 2014-2020

Table North America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Type from 2019-2020

Table North America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

Table North America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

Figure Europe Benign Prostatic Hyperplasia Production and Growth Rate from 2014-2020

Figure Europe Benign Prostatic Hyperplasia Consumption and Growth Rate from 2014-2020

Table Europe Benign Prostatic Hyperplasia Import and Export from 2014-2020

Table Europe Benign Prostatic Hyperplasia Value ($) and Growth (%) by Type from 2019-2020

Table Europe Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

Table Europe Benign Prostatic Hyperplasia Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Benign Prostatic Hyperplasia Production and Growth Rate from 2014-2020

Figure Asia-Pacific Benign Prostatic Hyperplasia Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Benign Prostatic Hyperplasia Import and Export from 2014-2020

Table Asia-Pacific Benign Prostatic Hyperplasia Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Benign Prostatic Hyperplasia Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

Figure Latin America Benign Prostatic Hyperplasia Production and Growth Rate from 2014-2020

Figure Latin America Benign Prostatic Hyperplasia Consumption and Growth Rate from 2014-2020

Table Latin America Benign Prostatic Hyperplasia Import and Export from 2014-2020

Table Latin America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Benign Prostatic Hyperplasia Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Benign Prostatic Hyperplasia Production and Growth Rate from 2014-2020

Figure Middle East & Africa Benign Prostatic Hyperplasia Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Benign Prostatic Hyperplasia Import and Export from 2014-2020

Table Middle East & Africa Benign Prostatic Hyperplasia Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Benign Prostatic Hyperplasia Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Benign Prostatic Hyperplasia Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Benign Prostatic Hyperplasia Participants Value ($) and Market Share (%) in 2019

Table Boehringer Ingelheim Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Boehringer Ingelheim Sales and Growth Rate from 2014-2020

Figure Boehringer Ingelheim Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Nymox Pharmaceutical Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Nymox Pharmaceutical Corporation Sales and Growth Rate from 2014-2020

Figure Nymox Pharmaceutical Corporation Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Allergan PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Allergan PLC Sales and Growth Rate from 2014-2020

Figure Allergan PLC Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sanofi Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sanofi Sales and Growth Rate from 2014-2020

Figure Sanofi Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Teva Pharmaceutical Industries Limited Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Teva Pharmaceutical Industries Limited Sales and Growth Rate from 2014-2020

Figure Teva Pharmaceutical Industries Limited Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer Inc. Sales and Growth Rate from 2014-2020

Figure Pfizer Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Eli Lilly and Company Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Eli Lilly and Company Sales and Growth Rate from 2014-2020

Figure Eli Lilly and Company Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Astellas Pharma Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Astellas Pharma Inc. Sales and Growth Rate from 2014-2020

Figure Astellas Pharma Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table GlaxoSmithKline PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure GlaxoSmithKline PLC Sales and Growth Rate from 2014-2020

Figure GlaxoSmithKline PLC Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sophiris Bio Corp. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sophiris Bio Corp. Sales and Growth Rate from 2014-2020

Figure Sophiris Bio Corp. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Benign Prostatic Hyperplasia Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Benign Prostatic Hyperplasia Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Benign Prostatic Hyperplasia Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Benign Prostatic Hyperplasia Production and Growth Rate Forecast by Types (2021-2026)

Table Global Benign Prostatic Hyperplasia Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390